Preclinical development of the CDK4 selective inhibitor PF-07220060: Increased CDK4 versus CDK6 inhibition leads to improved anti-tumor efficacy at therapeutic concentrations

被引：0
|
作者：
Anders, Lars
Pascual, Bernadette
Boras, Britton
Cianfrogna, Julie
Garza, Scott
Li, Na
Yuan, Jing Tang
Moen, Mark
Huser, Nanni
Gallego, Gary
Jalaie, Mehran
Ninkovic, Sacha
Cho-Schultz, Sujin
Shen, Hong
Kath, John
Dress, Klaus
Diehl, Wade
Nair, Sajiv
Jones, Rhys
Lafontaine, Jennifer
Murtaza, Anwar
Sacaan, Aida
Chintharlapalli, Sudhakar
VanArsdale, Todd
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
595
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of PF-07220060, a potent and selective CDK4 inhibitor
    Anders, Lars
    Gallego, Gary
    CANCER RESEARCH, 2024, 84 (07)
  • [2] CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
    Palmer, Cynthia L.
    Boras, Britton
    Pascual, Bernadette
    Li, Na
    Li, Danan
    Garza, Scott
    Huser, Nanni
    Yuan, Jing Tang
    Cianfrogna, Julie A.
    Sung, Tae
    Mcmillan, Elizabeth
    Wei, Na
    Carmody, Jason
    Kang, Aubrey Nayeon
    Darensburg, Seth
    Dodd, Taran
    Oakley, James, V
    Solowiej, James
    Nguyen, Lisa
    Orr, Suvi T. M.
    Chen, Ping
    Johnson, Eric
    Yu, Xiu
    Diehl, Wade C.
    Gallego, Gary M.
    Jalaie, Mehran
    Ferre, Rose Ann
    Cho-Schultz, Sujin
    Shen, Hong
    Deal, Judith G.
    Zhang, Qin
    Baffi, Timothy R.
    Xu, Meirong
    Roh, Whijae
    Lapira-Miller, Jennifer
    Goudeau, Jerome
    Yu, Yanke
    Gupta, Rajat
    Kim, Kimberly
    Dann, Stephen G.
    Kan, Zhengyan
    Kath, John C.
    Nair, Sajiv K.
    Miller, Nichol
    Murray, Brion W.
    Nager, Andrew R.
    Quinlan, Casey
    Petroski, Matthew D.
    Zhang, Cathy
    Sacaan, Aida
    CANCER CELL, 2025, 43 (03)
  • [3] Preclinical head-to-head comparison of CDK4/6 inhibitor activity toward CDK4 vs CDK6
    Delach, Scott
    Caponigro, Giordano
    CANCER RESEARCH, 2021, 81 (04)
  • [4] PALBOCICLIB Cyclin CDK4/CDK6 Inhibitor Oncolytic
    Haddley, K.
    DRUGS OF THE FUTURE, 2013, 38 (11) : 745 - 755
  • [5] The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib
    Gong Xueqian
    Chio, Li-Chun
    Webster, Yue
    Lallena, Maria Jose
    Boehnke, Karsten
    Torres, Raquel
    Iversen, Phil
    De Dios, Alfonso
    Smith, Ian
    Reinhard, Christoph
    Peng, Sheng-Bin
    Dempsey, Jack
    Burke, Teresa
    Chen, Shih-Hsun
    Stewart, Trent
    Beckmann, Richard
    Wu, Wenjuan
    Buchanan, Sean G.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [6] Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
    Raub, Thomas J.
    Wishart, Graham N.
    Kulanthaivel, Palaniappan
    Staton, Brian A.
    Ajamie, Rose T.
    Sawada, Geri A.
    Gelbert, Lawrence M.
    Shannon, Harlan E.
    Sanchez-Martinez, Concepcion
    De Dios, Alfonso
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (09) : 1360 - 1371
  • [7] Targeting prostate cancer with the CDK4 and CDK6 inhibitor abemaciclib
    Torres-Guzman, Raquel
    Baquero, Carmen
    Patricia Ganado, Maria
    Marugan, Carlos
    Bian, Huimin
    Zeng, Yi
    Rama, Ramon
    Du, Jian
    Jose Lallena, Maria
    CANCER RESEARCH, 2020, 80 (16)
  • [8] CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard
    Wolff, Antonio C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20): : 1993 - 1995
  • [9] Synergistic preclinical efficacy through combination of the CDK4 and CDK2 selective inhibitors, PF-07220060 and PF-07104091, respectively, in HR+HER2-breast cancer
    Anders, L.
    Van Arsdale, T.
    Chintharlapalli, S.
    Boras, B.
    Cianfrogna, J.
    Huser, N.
    Pascual, B.
    Shen, C.
    Qiu, M.
    Sacaan, A.
    Jones, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S365 - S365
  • [10] Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
    Martin, Miguel
    Garcia-Saenz, Jose A.
    Manso, Luis
    Llombart, Antonio
    Cassinello, Alejo
    Atienza, Manuel
    Ringeisen, Francois
    Ciruelos, Eva
    FUTURE ONCOLOGY, 2020, 16 (33) : 2763 - 2778
12345